Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS
Open Access
- 16 September 1993
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 329 (12), 828-833
- https://doi.org/10.1056/nejm199309163291202
Abstract
Disseminated Mycobacterium avium complex infection eventually develops in most patients with the acquired immunodeficiency syndrome (AIDS). This infection results in substantial morbidity and reduces survival by about six months.Keywords
This publication has 19 references indexed in Scilit:
- Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive PatientsThe Journal of Infectious Diseases, 1992
- Update on rifampin drug interactions. IIArchives of Internal Medicine, 1992
- Disseminated Mycobacterium avium Complex Infection: Clinical Identification and Epidemiologic TrendsThe Journal of Infectious Diseases, 1992
- Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDSThe Lancet, 1991
- Mycobacterium avium Infection and AIDS: A Therapeutic Dilemma in Rapid EvolutionThe Journal of Infectious Diseases, 1991
- Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Mycobacterium avium Complex InfectionThe Journal of Infectious Diseases, 1988
- Rifabutin (Ansamycin LM 427): A New Rifamycin-S Derivative for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1987
- Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- Mycobacterium avium-intracellulare: another scourge for individuals with the acquired immunodeficiency syndromePublished by American Medical Association (AMA) ,1982